К содержанию
РецензированоRU2022

Cardiovascular disease risk in patients with rheumatoid arthritis treated with conventional dmards: a сase control study

Ibragimov Kh.I. · Sultonov I.I. · Ziyadullayev Sh.X.

Научные статьи · 2022

Аннотация

Study objectives. This study examines possible associations between cardiovascular disease and the utilization of conventional DMARDs in patients with RA. Materials and methods. Using a case-control study design, 246 patients with RA (82 with CVD and 164 without CVD) were studied. Data on RA, CVD, and DMARDs therapy were assessed from the verified medical history data. Results and discussion. MTX treatment showed an association with a significant reduction in CVD risk: “MTX only”, OR 0.18 (95% CI 0.09-0.74); "MTX and SSZ ever", OR 0.22 (95% CI 0.12-0.53). After additional correction, the risk reductions with the treatment remained significant for rheumatoid factor presence.

Доказательный фрагмент

«Study objectives. This study examines possible associations between cardiovascular disease and the utilization of conventional DMARDs in patients with RA. Materials and methods. Using a case-control study design, 246…»

Образец извлечения

Демо-превью

Study objectives. This study examines possible associations between cardiovascular disease and the utilization of conventional DMARDs in patients with RA. Materials and methods. Using a case-control study design, 246… Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники